Medicare Part D Stand-Alone Plan Premiums Could Rise 50% to $51 Monthly in 2027 Without a Switch to Lower-Cost Coverage
-
By
-
kfftiffanyf
-
October 30, 2026
Clinical Scorecard: Medicare Part D Stand-Alone Plan Premiums Could Rise 50% to $51 Monthly in 2027 Without a Switch to Lower-Cost Coverage
At a Glance
| Category | Detail |
|---|---|
| Condition | Clinical topic addressed by the source article: Medicare Part D Stand-Alone Plan Premiums Could Rise 50% to $51 Monthly in 2027 Without a Switch to Lower-Cost Coverage |
| Key Mechanisms | KFF projects that the average monthly premium for stand-alone prescription drug plans will rise from $34 in 2026 to $51 in 2027. Most stand-alone plan enrollees who do not receive low-income subsidies will face higher premiums unless they switch to a less expensive plan; no zero-premium stand-alone plans are projected for 2027. |
| Target Population | Medicare Part D enrollees, particularly stand-alone prescription drug plan enrollees who do not receive low-income subsidies |
| Care Setting | Care setting described in the source article. |
Key Highlights
- KFF projects the average monthly premium for stand-alone prescription drug plans to rise from $34 in 2026 to $51 in 2027, a 50% increase.
- The projected average monthly premium for Medicare Advantage plans offering Part D coverage is $9 in 2027, compared with $51 for stand-alone plans.
- No zero-premium stand-alone plans are projected to be available in 2027; more than 4 million people are currently enrolled in such plans.
- The maximum Part D deductible may rise from $615 in 2026 to $700 in 2027; projected average deductibles are $643 for stand-alone plan enrollees and $489 for Medicare Advantage Part D enrollees.
- Coinsurance rather than copayments will apply to preferred brands and non-preferred drugs for most Part D enrollees.
Guideline-Based Recommendations
Diagnosis
Management
- The article says enrollees can compare plans and switch to lower-premium coverage during open enrollment, which continues through December 7.
- KFF vice president Juliette Cubanski said people facing sizable premium increases must act to avoid paying considerably more.
Monitoring & Follow-up
Risks
- Most stand-alone plan enrollees who do not receive low-income subsidies are projected to face higher premiums unless they switch; the average projected increase is $17 per month.
- Based on enrollees remaining in their current plans, 99.8% of stand-alone plan enrollees and 85% of Medicare Advantage Part D enrollees are projected to have deductibles of several hundred dollars in 2027.
- Coinsurance rather than copayments will apply to preferred brands and non-preferred drugs for most Part D enrollees, potentially making out-of-pocket costs less predictable.
Patient & Prescribing Data
Medicare Part D enrollees, including stand-alone prescription drug plan and Medicare Advantage Part D enrollees; the article notes that projections for higher premiums apply to most stand-alone plan enrollees who do not receive additional low-income subsidies.
For 2027, projected average monthly premiums are $51 for stand-alone plans and $9 for Medicare Advantage Part D coverage. Projected average deductibles are $643 and $489, respectively. The article describes plan-cost projections and enrollment choices, not medication prescribing.
Clinical Best Practices
Related Resources & Content
Based on findings from:
The Average Monthly Premium for Medicare Part D Stand-Alone Plans Is Projected to Increase by 50% From $34 to $51 in 2027 Unless Enrollees Switch to Lower-Cost Plans
kfftiffanyf. Kaiser Family Foundation, 2026.
https://www.kff.org/medicare/the-average-monthly-premium-for-medicare-part-d-stand-alone-plans-is-projected-to-increase-by-50-from-34-to-51-in-2027-unless-enrollees-switch-to-lower-cost-plans/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.